-
Residents recount guilt, chaos in hearing on deadly Hong Kong fire
-
Oil prices jump, stocks slip as Trump's Iran claims raise doubts
-
World Snooker Championship to stay at Crucible
-
Mercedes new electric VLE: Price and performance?
-
Outlook worsens for whale stranded on German coast
-
Xiaomi quarterly profit slumps despite annual EV gains
-
Iran, Israel trade strikes despite Trump talk of negotiations
-
IPL's Bengaluru to keep 11 seats empty in honour of stampede dead
-
Oil prices jump, stocks waver after Trump's Iran claim
-
'A top person': Who is the US dealing with in Iran?
-
In Lebanon's Tyre, ancient site threatened by Israeli bombs
-
US-Israeli war on Iran is 'breach of international law': German president
-
Iran strikes Israel, denies Trump talks
-
Mbappe says injury is behind him, all systems go for World Cup
-
Supporters' group file lawsuit against 'excessive' World Cup ticket prices
-
Gas shortages push India's poor back to wood and coal
-
'Plundered': Senegal fishers feel sting of illegal, industrial vessels
-
Iran hits Israel with missiles after denying Trump talks
-
Stocks rise on Trump U-turn but unease sees oil bounce
-
Trans community alarmed as India moves to curb LGBTQ rights
-
Families' nightmare fight for justice in Austria child sex cases
-
Tiger Woods to return to action in TGL with Masters looming
-
Australia, EU agree sweeping new trade pact eight years in the works
-
Back to black: facing energy shock, Asia turns to coal
-
Iran fires new wave of missiles at Israel after denying Trump talks
-
Manila's jeepney drivers struggle as Mideast war sends diesel cost soaring
-
The contenders vying to be next Danish leader
-
India's historic haveli homes caught between revival and ruin
-
Denmark votes in close election, outgoing PM tipped to win
-
N. Korea's Kim vows 'irreversible' nuclear status, warns Seoul of 'merciless' response
-
Pressure on Italy as play-off hopefuls eye 2026 World Cup
-
Malinin and Sakamoto seek solace at figure skating worlds as Olympic champions absent
-
'Perfect Japan' posts spark Gen Z social media backlash
-
Asian stocks rise on Trump U-turn but unease sees oil bounce
-
Pistons halt Lakers streak while Spurs, Thunder win
-
Silence not an option, says Canadian Sikh activist after fresh threats
-
Rennie shakes up All Blacks backroom team as 2027 World Cup looms
-
Australia, EU agree to sweeping new trade pact after eight years
-
Too old? The 92-year-old US judge handling Maduro case
-
Australia, EU agree sweeping new trade pact
-
Sinner, Sabalenka march on in Miami as more seeds crash out
-
US social media addiction trial jury struggles for consensus
-
EU 'concerned' by reports Hungary leaked information to Russia
-
USPA Global and ESPN Expand Relationship with Chris Fowler for 2026 High-Goal Polo Championships
-
EU chief meets Australian PM as trade talks enter 'last mile'
-
Israel pounds south Beirut, says captured Hezbollah members
-
EU chief to meet Australian PM as trade talks enter 'last mile'
-
Champion Mensik, Medvedev dumped out of Miami Open
-
Jury at US social media addiction trial reports 'difficulty' in finding consensus
-
Stokes eager to lead England recovery after 'hardest period of captaincy'
Moderna rebuked over plan to hike Covid vaccine to $130
Moderna's chief executive on Wednesday defended the US company's plan to quadruple the price of its lifesaving Covid vaccine to as much as $130 per dose as soon as government stockpiles run out.
Democratic Senator Bernie Sanders lashed out at the price hike, denouncing the "unprecedented level of corporate greed" in the pharmaceutical industry. "And that is certainly true with Moderna," Sanders said.
Moderna has so far charged between about $15 and $26 for doses of its vaccine, according to the Kaiser Family Foundation.
The US government subsidized $1.7 billion of Moderna's research at the start of the pandemic and then purchased $10 billion worth of vaccine, Sanders said at a Senate hearing where the company's CEO Stephane Bancel was testifying.
Sanders said Moderna was "thanking the taxpayers of the United States" by more than quadrupling the vaccine's price "at a time when it costs less than $3 to manufacture."
Sanders noted several times at the hearing that Moderna conducted buybacks of its own stock and paid its own executives at its Cambridge, Massachusetts, headquarters handsomely.
Bancel defended Moderna, saying the distribution system will change completely when the US government lifts a state of health emergency, perhaps as soon as May.
Up until now, Moderna had only one customer, distributed its vaccine to only a few warehouses and did not have to pay for the cost of expired doses.
By switching to a more traditional marketing approach, "we're going to have 10,000 customers" and have to "manage to deliver to 60,000 pharmacies, doctors' offices and hospitals," he added.
Currently distributed in multidose vials, the vaccine will be sold mostly in single-dose vials or directly in prefilled syringes. And Moderna will have to take care of the unsold doses.
The company expects a "90 percent reduction in demand," Bancel said. "We are losing economies of scale. We must assume the wastage risk and cost that the US government used to assume."
Moderna also pledged to set up a program so that the uninsured or underinsured would not have to pay anything.
When pressed by Sanders about the possibility of the company lowering its price for government-run health insurance programs, Bancel said discussions were underway with all customers.
V.AbuAwwad--SF-PST